What if we could use a cancer’s own byproduct to make drugs that destroy tumor cells from the inside? That is what Katsunori Tanaka and his team have done at the RIKEN Pioneering Research Institute (PRI) in Japan.
Related Posts
5 Best Organizations of 2026 for People With Psoriatic Arthritis
American College of Rheumatology Founded in 1934, the American College of Rheumatology (ACR) is the leading not-for-profit professional association, and it supports more than 9,600 […]
Hep B Vax Doses Seized; RFK Jr.’s Brazil Photos; MAHA Advisor’s COI Waiver
The Guinea-Bissau offices of controversial researchers who were going to use CDC funds to run a trial of a hepatitis B birth dose in that […]
White House Doctor Must Be Within 3 Minutes of Trump, Report Says
It’s not easy being the President’s physician, but the Wall Street Journal captured some of the biggest challenges facing Sean Barbabella, DO — including the […]